MA MAXHEALTH
Max Healthcare Institute Q1 2027
MAMAXHEALTH

Max Healthcare Institute Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 14 Aug 2026

Management summary

  • Max Healthcare Institute Limited delivered strong Q1 FY27 results with 16% YoY revenue growth and 15% YoY operating EBITDA growth.
  • High occupancy and ongoing capacity expansions..
  • While operating EBITDA margins were slightly muted due to new facility commissioning and the Kalinga acquisition, the company is strategically entering the medical education business with a projected ROCE exceeding 25%.
  • Challenges included a decline in oncology revenue and lower free cash flow growth attributed to increased accounts receivable.

Source: Inve concall analysis and management guidance record.

Highlights

  • Revenue of ₹2,982 crore, up 16% YoY and 12% QoQ.

  • Operating EBITDA of ₹704 crore, up 15% YoY and 3% QoQ.

  • Average occupancy for the Network continued to be more than 75% despite a 13% increase in operational bed capacity year-on-year.

  • International patient revenue was ₹247 crore, registering a growth of 18% year-on-year.

Why these two revenue figures differ: Management cited ₹2,982 Cr (Revenue) on the call, while the exchange-filed quarterly statement below reports ₹2,366 Cr — typically due to standalone vs. consolidated scope, revenue from operations vs. total income (including other income), or presentation adjustments.

What they filed

Q1 FY27: revenue up 16.7%, net profit up 4.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,868 1,910 2,028 2,135 2,068 +11%2,143 +12%2,366 +17%
EBITDA499 512 523 575 538 +8%606 +18%598 +14%
Net profit239 319 308 491 301 +26%342 +7%323 +5%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Guidance & targets

Capacity

  • Max Smart brownfield tower remaining capacity operationalization Capacity · current quarter · High confidence 50%
  • Nanavati Max remaining beds operationalization Capacity · current quarter · High confidence 50 beds

Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.

Q&A highlights

1 direct
Parliamentary Standing Committee Recommendation on Healthcare Partial
I think the recent committee report speaks about affordability, but one needs to look at another important aspect, which is going to be the need for new hospital beds and viability. I think both need to go hand-in-hand. Once you take that equation into account, I think wise minds

Analyst sought management's view on potential regulatory changes impacting hospital viability, which management acknowledged but downplayed immediate concerns.

Asked by Damayanti Kerai

Kalinga Hospital Turnaround Strategy and Profitability Direct
Yes, because the occupancy is 50% and ARPOB is INR 35,000, we think there is a significant headroom for growth in both of these. You should be able to effectively have a 50% to 80% enhancement in both of these. And in order to do that, we have a current running hospital, so we ha

Analyst questioned the low profitability of the recent acquisition, and management provided a clear roadmap and targets for improvement over the next year.

Asked by Damayanti Kerai

Unlock risks & concerns, Q2 FY27 watchlist, and full call analysis

You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:

  • 9 risks, concerns & management red flags
  • 5 watchlist triggers for Q2 FY27
  • +18 more guidance targets & verbatim management quotes
  • +6 more analyst Q&A exchanges & evasion checks
  • Capital allocation & full section-by-section narrative

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image